Adrenal suppression in an asthmatic presenting after change from high dose inhaled fluticasone propionate to inhaled budesonide

被引：0
|
作者：
Zainab B Abdurahman
Douglas P Mack
机构：
[1] McMaster University,Dept of Clinical Immunology and Allergy
[2] McMaster University,Dept of Pediatrics
来源：
Allergy, Asthma & Clinical Immunology | / 6卷 / Suppl 2期
关键词：
Rhinitis; Allergic Rhinitis; Budesonide; Fluticasone; Fluticasone Propionate;
D O I：
10.1186/1710-1492-6-S2-P27
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate
    Fowler, SJ
    Orr, LC
    Wilson, AM
    Sims, EJ
    Lipworth, BJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 (01) : 93 - 95
  • [32] Utility and efficacy of fluticasone propionate and salmeterol inhaled from a single inhaler for persistent asthma
    Mathison, DA
    Koziol, JA
    JOURNAL OF ASTHMA, 2005, 42 (10) : 829 - 831
  • [33] A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler
    Grahnen, A
    Jansson, B
    Brundin, RM
    LingAndersson, A
    Lonnebo, A
    Johansson, M
    Eckernas, SA
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 52 (04) : 261 - 267
  • [34] Evidence of hypothalamic-pituitary-adrenal axis suppression during moderate-to-high-dose inhaled corticosteroid use
    Cavkaytar, Ozlem
    Vuralli, Dogus
    Yilmaz, Ebru Arik
    Buyuktiryaki, Betul
    Soyer, Ozge
    Sahiner, Umit M.
    Kandemir, Nurgun
    Sekerel, Bulent E.
    EUROPEAN JOURNAL OF PEDIATRICS, 2015, 174 (11) : 1421 - 1431
  • [35] Budesonide use and misuse in sports: Elimination profiles of budesonide and metabolites after intranasal, high-dose inhaled and oral administrations
    Coll, Sergi
    Monfort, Nuria
    Matabosch, Xavier
    Papakonstantinou, Katerina
    Perez-Mana, Clara
    Mateus, Julian A.
    Ventura, Rosa
    DRUG TESTING AND ANALYSIS, 2020, 12 (05) : 629 - 636
  • [36] High-dose inhaled budesonide may substitute for oral therapy after an acute asthma attack
    Nana, A
    Youngchaiyud, P
    Charoenratanakul, S
    Boe, J
    Löfdahl, CG
    Selroos, O
    Ståhl, E
    JOURNAL OF ASTHMA, 1998, 35 (08) : 647 - 655
  • [37] Acute adrenal crisis in asthmatics treated with high-dose fluticasone propionate
    Todd, GRG
    Acerini, CL
    Buck, JJ
    Murphy, NP
    Ross-Russell, R
    Warner, JT
    McCance, DR
    EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (06) : 1207 - 1209
  • [38] Cushing's syndrome with adrenal suppression induced by inhaled budesonide due to a ritonavir drug interaction in a woman with HIV infection
    Yoganathan, K.
    David, L.
    Williams, C.
    Jones, K.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2012, 23 (07) : 520 - 521
  • [39] HIGH-DOSE FLUTICASONE PROPIONATE, 1 MG DAILY, VERSUS FLUTICASONE PROPIONATE, 2 MG DAILY, OR BUDESONIDE, 1.6 MG DAILY, IN PATIENTS WITH CHRONIC SEVERE ASTHMA
    AYRES, JG
    BATEMAN, ED
    LUNDBACK, B
    HARRIS, TAJ
    EUROPEAN RESPIRATORY JOURNAL, 1995, 8 (04) : 579 - 586
  • [40] The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial
    Chris Dalby
    Tomasz Polanowski
    Thomas Larsson
    Lars Borgström
    Staffan Edsbäcker
    Tim W Harrison
    Respiratory Research, 10
12345